1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY TECHNOLOGY TYPE

5.1. Introduction

5.2. Immunodiagnostics

5.3. Molecular Diagnostics

5.4. Hematology

5.5. Urinalysis

5.6. Others

6. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY PATHOGEN TYPE

6.1. Introduction

6.2. Virus

6.3. Bacteria

6.4. Parasite

6.5. Others

7. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY ANIMAL TYPE

7.1. Introduction

7.2. Companion Animal

7.2.1. Cats

7.2.2. Dogs

7.2.3. Horse

7.2.4. Others

7.3. Livestock

7.3.1. Cattle

7.3.2. Swine

7.3.3. Sheep

7.3.4. Others

8. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY END-USER

8.1. Introduction

8.2. Diagnostics Laboratories

8.3. Veterinary Clinics

8.4. Research Centers

9. GLOBAL VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Spain

9.4.5. Italy

9.4.6. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. Australia

9.6.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. BIOMÉRIEUX S.A.

11.2. Chembio Diagnostics, Inc.

11.3. Heska Corporation

11.4. IDEXX Laboratories, Inc.

11.5. INDICAL BIOSCIENCE GmbH

11.6. Neogen Corporation

11.7. QIAGEN N.V.

11.8. Randox Laboratories Ltd.

11.9. Thermo Fisher Scientific Inc.

11.10. Virbac

11.11. Zoetis Inc.

12. APPENDIX

12.1. Currency

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology

12.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES